T. Rowe Price Associates »

Cg Oncology shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Cg Oncology shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $44M 992k 43.90

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Fiserv Comm Stk (FI)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
BlackRock
Vanguard Group
BVF
Henderson Group
Avidity Partners Management
RA Capital Management
Perceptive Advisors
Braidwell
T. Rowe Price Associates
Alliancebernstein
ABG-WTT Global Life Science Capital Partners GP
Franklin Resources
Cormorant Asset Management

View all funds holding Cg Oncology